Login / Signup

Intravenous fosfomycin: the underdog player in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

Maurizio GuastalegnameEnrico Maria TrecarichiAlessandro Russo
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Keyphrases
  • acinetobacter baumannii
  • multidrug resistant
  • drug resistant
  • pseudomonas aeruginosa
  • gram negative
  • high dose
  • low dose
  • urinary tract infection